Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria escherichia coli

Infection and Immunity

Volumn 80, Issue 1, 2012, Pages 333-344

  Watts, Rebecca E ^a   Totsika, Makrina ^a   Challinor, Victoria L ^a   Mabbett, Amanda N ^a   Ulett, Glen C ^b   Voss, James J De ^a   Schembri, Mark A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBACTIN; AMPICILLIN; CHLORAMPHENICOL; ENTEROCHELIN; FERRIC CITRATE; IRON; SALMOCHELIN; SIDEROPHORE; UNCLASSIFIED DRUG; YERSINIABACTIN; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM MUTANT; BACTERIURIA; BIOSYNTHESIS; CULTURE MEDIUM; ESCHERICHIA COLI; FEMALE; GENE DELETION; IRON TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; URINARY TRACT INFECTION; URINE; WILD TYPE; ANIMAL; C3H MOUSE; CHEMISTRY; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; PATHOGENICITY; URINARY TRACT;

ANIMALS; BACTERIURIA; CULTURE MEDIA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENE DELETION; HUMANS; IRON; MICE; MICE, INBRED C3H; SIDEROPHORES; URINARY TRACT; URINARY TRACT INFECTIONS; URINE; VIRULENCE FACTORS;

EID: 84857087300     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05594-11     Document Type: Article

References (68)

1. Allsopp LP, et al. 2010. UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect. Immun. 78:1659-1669.
2. Alteri CJ, Hagan EC, Sivick KE, Smith SN, Mobley HLT. 2009. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 5:e1000586.
3. Alteri CJ, Mobley HLT. 2007. Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect. Immun. 75:2679-2688.
4. Andersson P, et al. 1991. Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect. Immun. 59:2915-2921.
5. Bäumler AJ, et al. 1998. IroN, a novel outer membrane siderophore receptor characteristic of Salmonella enterica. J. Bacteriol. 180:1446-1453.
6. Bearden SW, Fetherston JD, Perry RD. 1997. Genetic organization of the yersiniabactin biosynthetic region and construction of avirulent mutants in Yersinia pestis. Infect. Immun. 65:1659-1668.
7. Benjamin WH Jr, Turnbough CL, Posey BS, Briles DE. 1985. The ability of Salmonella typhimurium to produce the siderophore enterobactin is not a virulence factor in mouse typhoid. Infect. Immun. 50:392-397.
8. Braun V. 2003. Iron uptake by Escherichia coli. Front. Biosci. 8:S1409-S1421.
9. Brock JH, Williams PH, Licéaga J, Wooldridge KG. 1991. Relative availability of transferrin-bound iron and cell-derived iron to aerobactinproducing and enterochelin-producing strains of Escherichia coli and to other microorganisms. Infect. Immun. 59:3185-3190.
10. Caza M, Lépine F, Dozois CM. 2011. Secretion, but not overall synthesis, of catecholate siderophores contributes to virulence of extra-intestinal pathogenic Escherichia coli. Mol. Microbiol. 80:266-282.
11. Chu BC, et al. 2010. Siderophore uptake in bacteria and the battle for iron with the host: a bird's eye view. Biometals 23:601- 611.
12. Cox GB, et al. 1970. Mutations affecting iron transport in Escherichia coli. J. Bacteriol. 104:219-226.
13. Crouch MLV, Castor M, Karlinsey JE, Kalhorn T, Fang FC. 2008. Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol. Microbiol. 67:971-983.
14. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
15. De Vos D, et al. 2001. Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch. Microbiol. 175:384-388.
16. Feldmann F, Sorsa LJ, Hildinger K, Schubert S. 2007. The salmochelin siderophore receptor IroN contributes to invasion of urothelial cells by extraintestinal pathogenic Escherichia coli in vitro. Infect. Immun. 75: 3183-3187.
17. Ferrières L, Hancock V, Klemm P. 2007. Biofilm exclusion of uropathogenic bacteria by selected asymptomatic bacteriuria Escherichia coli strains. Microbiology 153:1711-1719.
18. Fetherston JD, Kirillina O, Bobrov AG, Paulley JT, Perry RD. 2010. The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague. Infect. Immun. 78:2045-2052.
19. Fischbach MA, et al. 2006. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc. Natl. Acad. Sci. U. S. A. 103:16502-16507.
20. Fluckinger M, Haas H, Merschak P, Glasgow BJ, Redl B. 2004. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob. Agents Chemother. 48:3367-3372.
21. Foxman, B. 2002. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113(Suppl. 1A):S5-S13.
22. Furman M, Fica A, Saxena M, Di Fabio JL, Cabello FC. 1994. Salmonella typhi iron uptake mutants are attenuated in mice. Infect. Immun. 62: 4091-4094.
23. Garcia EC, Brumbaugh AR, Mobley HLT. 2011. Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect. Immun. 79:1225-1235.
24. Goetz DH, et al. 2002. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10:1033-1043.
25. - and tonB mutants of Salmonella enterica serovar Typhi is human Mono Mac 6 monocytic cells. FEMS Microbiol. Lett. 196:7-11.
26. Griffin AS, West SA, Buckling A. 2004. Cooperation and competition in pathogenic bacteria. Nature 430:1024-1027.
27. Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HL. 2010. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog. 6:e1001187.
28. Hancock V, Ferrières L, Klemm P. 2008. The ferric yersiniabactin uptake receptor FyuA is required for efficient biofilm formation by urinary tract infectious Escherichia coli in human urine. Microbiology 154:167-175.
29. Hancock V, Seshasayee AS, Ussery DW, Luscombe NM, Klemm P. 2008. Transcriptomics and adaptive genomics of the asymptomatic bacteriuria Escherichia coli strain 83972. Mol. Genet. Genomics 279:523-534.
30. Hantke, K. 1990. Dihydroxybenzolyserine-a siderophore for Escherichia coli. FEMS Microbiol. Lett. 67:5- 8.
31. Hantke K, Nicholson G, Rabsch W, Winkelmann G. 2003. Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc. Natl. Acad. Sci. U. S. A. 100:3677-3682.
32. Henderson JP, et al. 2009. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog. 5:e1000305.
33. Hull R, et al. 2000. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J. Urol. 163:872- 877.
34. Jiricny N, et al. 2010. Fitness correlates with the extent of cheating in a bacterium. J. Evol. Biol. 23:738-747.
35. Jones AM, Lindow SE, Wildermuth MC. 2007. Salicylic acid, yersiniabactin, and pyoverdin production by the model phytopathogen Pseudomonas syringae pv. tomato DC3000: synthesis, regulation, and impact on tomato and Arabidopsis host plants. J. Bacteriol. 189:6773- 6786.
36. Klemm P, Hancock V, Schembri MA. 2007. Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect. Immun. 75:3688-3695.
37. Klemm P, Roos V, Ulett GC, Svanborg C, Schembri MA. 2006. Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect. Immun. 74:781-785.
38. Konopka K, Neilands JB. 1984. Effect of serum albumin on siderophoremediated utilization of transferrin iron. Biochemistry 23:2122-2127.
39. Kwon O, Hudspeth MES, Meganathan R. 1996. Anaerobic biosynthesis of enterobactin in Escherichia coli: regulation of entC gene expression and evidence against its involvement in menaquinone (vitamin K2) biosynthesis. J. Bacteriol. 178:3252-3259.
40. Lawlor MS, O'Connor C, Miller VL. 2007. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect. Immun. 75:1463-1472.
41. Léveillé S, et al. 2006. Iha from an Escherichia coli urinary tract infection outbreak clonal group A strain is expressed in vivo in the mouse urinary tract and functions as a catecholate siderophore receptor. Infect. Immun. 74:3427-3436.
42. Lindberg U, et al. 1975. Asymptomatic bacteriuria in schoolgirls. II. Differences in Escherichia coli causing asymptomatic and symptomatic bacteriuria. Acta Paediatr. Scand. 64:432- 436.
43. Mabbett AN, et al. 2009. Virulence properties of asymptomatic bacteriuria Escherichia coli. Int. J. Med. Microbiol. 299:53- 63.
44. Miethke M, Marahiel MA. 2007. Siderophore-based iron acquisition and pathogen control. Microbiol. Mol. Biol. Rev. 71:413- 451.
45. Nègre VL, et al. 2004. The siderophore receptor IroN, but not the highpathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitis. Infect. Immun. 72: 1216-1220.
46. Payne SM. 1994. Detection, isolation, and characterization of siderophores. Methods Enzymol. 235:329-344.
47. Perry RD, Balbo PB, Jones HA, Fetherston JD, DeMoll E. 1999. Yersiniabactin from Yersinia pestis: biochemical characterization of the siderophore and its role in iron transport and regulation. Microbiology 145: 1181-1190.
48. Rabsch W, et al. 2003. Role of receptor proteins for enterobactin and 2,3-dihydroxybenzoylserine in virulence of Salmonella enterica. Infect. Immun. 71:6953- 6961.
49. Rabsch W, Voigt W, Reissbrodt R, Tsolis RM, Bäumler AJ. 1999. Salmonella typhimurium IroN and FepA proteins mediate uptake of enterobactin but differ in their specificity for other siderophores. J. Bacteriol. 181:3610-3612.
50. Raymond KN, Carrano CJ. 1979. Coordination chemistry and microbial iron transport. Acc. Chem. Res. 12:183-190.
51. Ronald A. 2003. The etiology of urinary tract infection: traditional and emerging pathogens. Dis. Mon. 49:71- 82.
52. Roos V, Klemm P. 2006. Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect. Immun. 74:3565-3575.
53. Roos V, Schembri MA, Ulett GC, Klemm P. 2006. Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae. Microbiology 152:1799-1806.
54. Roos V, Ulett GC, Schembri MA, Klemm P. 2006. The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect. Immun. 74:615- 624.
55. Russo TA, et al. 2002. IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect. Immun. 70:7156-7160.
56. Schubert S, Picard B, Gouriou S, Heesemann J, Denamur E. 2002. Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections. Infect. Immun. 70:5335-5337.
57. Schwyn B, Neilands JB. 1987. Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 160:47-56.
58. Snyder JA, et al. 2004. Transcriptome of uropathogenic Eschetichia coli during urinary tract infection. Infect. Immun. 72:6373- 6381.
59. Sundén F, Håkansson L, Ljunggren E, Wullt B. 2006. Bacterial interference- is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection? Int. J. Antimicrob. Agents 28:S26-S29.
60. Torres AG, Redford P, Welch RA, Payne SM. 2001. TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse. Infect. Immun. 69: 6179-6185.
61. Tsolis RM, Bäumler AJ, Heffron F, Stojiljkovic I. 1996. Contribution of TonB- and Feo-mediated iron uptake to growth of Salmonella typhimurium in the mouse. Infect. Immun. 64:4549-4556.
62. Valdebenito M, Crumbliss AL, Winkelmann G, Hantke K. 2006. Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917. Int. J. Med. Microbiol. 296:513-520.
63. Wells M, Gösch M, Harms H, van der Meer JR. 2005. Response characteristics of arsenic-sensitive bioreporters expressing the gfp reporter gene. Microchim. Acta 151:209-216.
64. Wullt B, et al. 2001. P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell. Microbiol. 3:255-264.
65. Wullt B, et al. 1998. Urodynamic factors influence the duration of Escherichia coli bacteriuria in deliberately colonized cases. J. Urol. 159: 2057-2062.
66. Yancey RJ, Breeding SAL, Lankford CE. 1979. Enterochelin (enterobactin): virulence factor for Salmonella typhimurium. Infect. Immun. 24:174-180.
67. Zdziarski J, et al. 2010. Host imprints on bacterial genomes- rapid, divergent evolution in individual patients. PLoS Pathog. 6:e1001078.
68. Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U. 2008. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect. Immun. 76:695-703.